Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13

Long-term safety of tiotropium/olodaterol Respimat® in patients with moderate-to-very severe COPD and renal impairment in the TONADO® studies

Total article views   HTML views PDF downloads Totals
14,075 Dovepress* 11,539+ 1,587 13,126
PubMed Central* 2,536 300 2,836
Totals 14,075 1,887 15,962
*Since 1 June 2018
Total mentioned Facebook Delicious Reddit Twitter Others
12 0 0 0 5 7

View citations on PubMed Central and Google Scholar